Elimination des Fibrins

  • U. Bleyl
Conference paper

Zusammenfassung

Fibrin tritt in der Blutbahn bekanntlich in verschiedenen Formen auf, als lösliches zirkulierendes Fibrin (Fibrinmonomer, Fibrinmonomer-Fibrinogen-Komplex bzw. Fibrinoligomer) und als unlösliches, hochpolymeres, periodenkoinzident quervernetztes, „korpuskuläres“ und dadurch zunehmend zirkulationsunfähiges Derivat. Die Elimination dieser heterogenen Fibrinformen folgt entsprechend der unterschiedlichen Löslichkeit dieser Derivate wesensverschiedenen Prinzipien.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Allen C, Saga TM, Molnar J (1973) Isolation, purification and characterization of opsonic protein. J Reticuloendothel Soc 13: 410–423PubMedGoogle Scholar
  2. 2.
    Benzer H (1975) Oberflachenspannung in der Lunge and Schocklunge. Verh Dtsch Ges Inn Med 81: 455 - 462PubMedGoogle Scholar
  3. 3.
    Bergström J, Fürst P (1978) Uremic toxins. Kidney Intern 13: 5CrossRefGoogle Scholar
  4. 4.
    Bleyl U (1971) Pathomorphologie und Pathogenese des Atemnotsyndroms. Verh Dtsch Ges Pathol 55: 39–72PubMedGoogle Scholar
  5. 5.
    Bleyl U (1978) Haemostase und Schocklunge. Verh Dtsch Ges Pathol 62: 39–54Google Scholar
  6. 6.
    Bleyl U, Kuhn W, Graeff H (1969) Reticuloendothelial Clearance intravasaler Fibrin- monomere in der Milz. Thromb Diath Haemorrh (Stuttg) 22: 87–100Google Scholar
  7. 7.
    Bleyl U, Nagel W (1968) Untersuchungen zur leukocytären Fibrinolyse. Klin Wochenschr 46: 413–415PubMedCrossRefGoogle Scholar
  8. 8.
    Bleyl U, Rieger P, Rossner JA (1978) Indentification of soluble fibrinogen fibrin monomer complexes by non-enzymatic polymerisation in the tissue. Virchows Arch [Pathol Anat] 378: 67–74CrossRefGoogle Scholar
  9. 9.
    Bleyl U, Rossner JA (1976) Globular hyaline microthrombi, their nature and morphogenesis. Virchows Arch [Pathol Anat] 370: 113–128CrossRefGoogle Scholar
  10. 10.
    Blumenstock F, Saba TM, Weber P, Cho E (1976) Purification and biochemical char-acterization of a macrophage stimulating alpha-2-globulin opsonic protein. J Reticuloendothel Soc 19: 157–172PubMedGoogle Scholar
  11. 11.
    Busch G, Gerdin B (1977) Effect of low molecular weight fibrin degradation products on endothelial cells in culture. 1st Scandinavian Symposium on Atherosclerosis Research StockholmGoogle Scholar
  12. 12.
    Camiolo SM, Thorsen S, Astrup S (1971) Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase - activated human globulin, and plasmin. Proc Soc Exper Biol Med 138: 277 - 280Google Scholar
  13. 13.
    Cash JD (1978) Control mechanisms of activator release. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis. Raven Press, New York, pp 65–75Google Scholar
  14. 14.
    Chang ML, Bang NU, Truex L, Boxer L, Mattler LE, Marks CA (1977) Degradation of soluble fibrin complexes, fibrinogen and fibrin by macrophage enzymes. Thromb. Haemost (Stuttg) 38: 102 (Abstract)Google Scholar
  15. 15.
    Cole ER, Bachmann FW (1977) Purification and properties of a plasminogen activator from pig heart. J Biol Chem 252: 3729–3737PubMedGoogle Scholar
  16. 16.
    Collen D (1980) On the regulation an control of fibrinolysis. Thromb Haemost (Stuttg) 43: 77–89Google Scholar
  17. 17.
    Emeis J J, Lindemann J (1976) Rat liver macrophages will not phagocytose fibrin during disseminated intravascular coagulation. Haemostasis 5: 193–210PubMedGoogle Scholar
  18. 18.
    Gans H, Lowman JT (1967) The uptake of fibrin and fibrin-degradation products by the isolated perfused rat liver. Blood 29: 526–539PubMedGoogle Scholar
  19. 19.
    Gerdin B, Belew M, Lindquist O, Saldeen T (1979) Effect of an fibrin derived peptide on pulmonary microvascular permeability. In: Saldeen T(ed) The microembolism syndromeGoogle Scholar
  20. 20.
    Gordon S, Cohn ZA (1978) Bacille Calmette-Guerin infection in the mouse. Regulation on macrophage plasminogen activator by T-lymphocytes and specific antigen. J Exp Med 147: 1175–1188PubMedCrossRefGoogle Scholar
  21. 21.
    Granelli-Piperno A, Vassali JD, Reich E (1977) Secretion of plasminogen activator by human polymorphnuclear leucocytes. J Exp Med 146: 1693–1706PubMedCrossRefGoogle Scholar
  22. 22.
    Griffin JH (1978) Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci 75: 1998–2002PubMedCrossRefGoogle Scholar
  23. 23.
    Hamilton J, Vassali JD, Reich R (1976) Macrophage plasminogen activator: induction by asbestos is blocked by antiinflammatory steroids. J Exp Med 144: 1689 - 1694PubMedCrossRefGoogle Scholar
  24. 24.
    Henry RL (1965) Leukocytes and thrombosis. Thromb Diath Haemorrh (Stuttg) 13: 35–46Google Scholar
  25. 25.
    Hisano S, Sueishi K, Ishij Y, Tanaka K (1979) Immunhistochemical and histochemical investigations on in vivo thrombosis with urokinase in rabbits. Thromb Haemost (Stuttg) 41: 796–803Google Scholar
  26. 26.
    Kaplan AP, Castellino FJ, Collen D, Wiman B, Taylor FB (1978) Molecular mechanisms of fibrinolysis in man. Thromb Haemost (Stuttg) 39: 263–283Google Scholar
  27. 27.
    Kaplan JE, Saba TM (1976) Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol 230: 7–14PubMedGoogle Scholar
  28. 28.
    Lewis JH, Szeto IL (1965) Clearance of infused fibrin. Fed Proc 24: 840–845PubMedGoogle Scholar
  29. 29.
    Lopaciuk S, Bykowska K, Kaczanowska J, Stachurska J, Jelenska M, Kopec M (1979) Effects of neutral proteases of human granulocytes on factor XIII and fibrinogen. Thromb Haemost (Stuttg) 42: 228Google Scholar
  30. 30.
    Mosesson MW, Umfleet RA (1970) The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and human relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem 245: 5728–5736PubMedGoogle Scholar
  31. 31.
    Mullertz S (1953) Plasminogen activator in spontaneously active human blood. Proc Soc Exper Biol Med 82: 291–295Google Scholar
  32. 32.
    Mullertz S (1956) Mechanism of activation and effect of plasmin in blood. Ph.D. Thesis. Munksgaard, CopenhagenGoogle Scholar
  33. 33.
    Niewiarowski S, Prou-Wartelle O (1959) Role of the contact factor (Hageman factor) in fibrinolysis. Thromb Diath Haemorrh 3: 593–603PubMedGoogle Scholar
  34. 34.
    Ogston D, Ogston CM, Ratnoff OD, Forbes CD (1969) Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest 48: 1786–1801PubMedCrossRefGoogle Scholar
  35. 35.
    Okamoto U, Nagamatsu Y, Anemiya T (1981) Human spleen insoluble fibrinolytic proteinase acting at neutral pH: its partial purification and characterization. Thromb Haemost (Stuttg) 45: 180–185Google Scholar
  36. 36.
    Plow EF, Edington TS (1975) The cleavage of fibrinogen by leukocyte proteases at physiological pH. J Clin Invest 56: 30–38PubMedCrossRefGoogle Scholar
  37. 37.
    Prose PH, Lee L, Balk SD (1965) Electron microscopic study of the phagocytic fibrin- clearing mechanism. Am J Pathol 47: 403–417PubMedGoogle Scholar
  38. 38.
    Rakoczi I, Wiman B, Colleen D (1978) On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta 540: 295–300PubMedGoogle Scholar
  39. 39.
    Ratliff NB, Wilson JW, Mikat E, Hackel DB (1970) Altered leukozytes in pulmonary vessels of dogs in hemorrhagic shock. Microvasc Res 2: 241–256Google Scholar
  40. 40.
    Rijken DC, Wijngaards G, Zaal-de Jong M, Welbergen J (1979) Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 580: 140–153PubMedGoogle Scholar
  41. 41.
    Risberg B, Heideman M (1980) The cascade systems in posttraumatic pulmonary insuf-ficiency. Acta Chir Scand [Suppl] 499: 107Google Scholar
  42. 42.
    Riifer R (1971) Surfactant inhibition in vitro. X XV. Internat. Congr. of Physiol. Sciences. Proceedings of the International Union of Physiol. Sciences IX.Google Scholar
  43. 43.
    Ruoslahti E, Vaheri A (1976) Immunological interspecies cross reaction of fibroblast surface antigen (Fibronectin). Immunochemistry 13: 639–642PubMedCrossRefGoogle Scholar
  44. 44.
    Saba TM (1975) Reticuloendothelial systemic host defense after surgery and traumatic shock. Circulat Shock 2: 91–107Google Scholar
  45. 45.
    Saba TM, Blumenstock FA, Scovill WA, Bernhard H (1978) Cryoprecipitate reversal of opsonic-2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science 201: 622–624PubMedCrossRefGoogle Scholar
  46. 46.
    Saldeen T (1980) Fibrin derived peptides as mediators of increased vascular permeability. Acta Chir Scand [Suppl] 499: 67Google Scholar
  47. 47.
    Schneider J, Baggiolini M (1978) Role of phagocytosis in the activation of macrophages. J Exp Med 148: 1449–1457CrossRefGoogle Scholar
  48. 48.
    Schreiner GE (1975) The search for the uremic toxin. Kidney Int 1: 5Google Scholar
  49. 49.
    Schreiner GE, Winchester JF (1979) Uremia - 1978 perspective. Chir Nephrol 2: 52Google Scholar
  50. 50.
    Sherman LA, Harwig S, Lee J (1975) In vitro formation and in vivo clearance of fibrinogen fibrin complexes. J Laborat Clin Med 86: 100–111Google Scholar
  51. 51.
    Sherman LA, Lee J (1977) Specific binding of soluble fibrin to macrophages. J Exp Med 145: 76 - 85PubMedCrossRefGoogle Scholar
  52. 52.
    Sherman LA, Lee J, Jacobson A (1977) Quantitation of the reticuloendothelial system clearance of soluble fibrin. Br J Haematol 37: 231–238PubMedCrossRefGoogle Scholar
  53. 53.
    Shermann LA, Lee J, Stewart CC (1977) Release of fibrinolytic enzymes by macrophages in response to soluble fibrin. Thromb Haemost (Stuttg) 38: 46Google Scholar
  54. 54.
    Starkey PM, Barrett AJ (1976) Neutral proteinases of human spleen. Purification and criteria for homogenicity of elastase and cathepsin G. Biochem J 155: 225–263Google Scholar
  55. 55.
    Stemberger A, Hormann H (1976) Affinity chromatography on immobilized fibrinogen and fibrin monomer. II. The behavior of cold-insoluble globulin. Hoppe-Seyler’s Z Physiol Chem 357: 1003–1005PubMedGoogle Scholar
  56. 56.
    Sueishi K, Nanno S, Tanaka K (1981) Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb Haemost (Stuttg) 45: 90–94Google Scholar
  57. 57.
    Thorsen S (1975) Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-amino-carboxylic acids. Biochim Biophys Acta 393: 55–65PubMedGoogle Scholar
  58. 58.
    Thorsen S (1977) Human urokinase and porcine tissue plasminogen activator. Thesis, University of CopenhagenGoogle Scholar
  59. 59.
    Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139: 834–850PubMedCrossRefGoogle Scholar
  60. 60.
    Vassalli JD, Hamilton J, Reich E (1976) Macrophage plasminogen activator: Modulation of enzyme production by antiinflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell 8: 271–281PubMedCrossRefGoogle Scholar
  61. 61.
    Wallen P (1977) Activation of plasminogen with urokinase and tissue activator. In: Paoletti R, Sherry S (eds) Thrombosis and urokinase. Academic Press, London, pp 91–102Google Scholar
  62. 62.
    Werb Z, Foley R, Munck A (1978) Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage cell line. J Immunol 121: 115–121PubMedGoogle Scholar
  63. 63.
    Werb Z, Foley R, Munck A (1978) Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages. J Exp Med 147: 1684–1694PubMedCrossRefGoogle Scholar
  64. 64.
    Wichert P von (1978) Alveolarwandphysiologie und Surfactant. Verh Dtsch Ges Pathol 62: 29–36Google Scholar
  65. 65.
    Wilson JW (1972) Pulmonary factors produced by septic shock: Cause or consequence of shock lung? J Reprod Med 8: 307PubMedGoogle Scholar
  66. 66.
    Wiman B, Wallen P (1977) The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb Res 10: 213–222PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • U. Bleyl

There are no affiliations available

Personalised recommendations